Cognizant (Nasdaq: CTSH), a leading provider of information technology, consulting, and business process services, today announced its participation in the following investor conferences: Morgan...

KTX-2001 is being evaluated in the Phase 1 STRIKE-001 clinical trial both as a monotherapy and in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC)...

Previously unpublished clinical data support the potential long‑term safety and efficacy of collagenase clostridium histolyticum (CCH) for plantar fibromatosis. The findings will be presented at...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...

The Quaint Quant Conference—the South's only dedicated quantitative finance event—returns on Friday, April 10, 2026, hosted at the SMU Cox School of Business in Dallas. Now in its fourth year,...